Department Otolaryngology-Head and Neck Surgery, Amsterdam UMC location Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Cancer Center Amsterdam, Treatment and Quality of Life, Amsterdam, The Netherlands.
Support Care Cancer. 2023 Jul 11;31(8):458. doi: 10.1007/s00520-023-07918-w.
The aim of this prospective cohort study was to estimate the relationship between the course of HRQOL in the first 2 years after diagnosis and treatment of head and neck cancer (HNC) and personal, clinical, psychological, physical, social, lifestyle, HNC-related, and biological factors.
Data were used from 638 HNC patients of the NETherlands QUality of life and BIomedical Cohort study (NET-QUBIC). Linear mixed models were used to investigate factors associated with the course of HRQOL (EORTC QLQ-C30 global quality of life (QL) and summary score (SumSc)) from baseline to 3, 6, 12, and 24 months after treatment.
Baseline depressive symptoms, social contacts, and oral pain were significantly associated with the course of QL from baseline to 24 months. Tumor subsite and baseline social eating, stress (hyperarousal), coughing, feeling ill, and IL-10 were associated with the course of SumSc. Post-treatment social contacts and stress (avoidance) were significantly associated with the course of QL from 6 to 24 months, and social contacts and weight loss with the course of SumSc. The course of SumSc from 6 to 24 months was also significantly associated with a change in financial problems, speech problems, weight loss, and shoulder problems between baseline and 6 months.
Baseline clinical, psychological, social, lifestyle, HNC-related, and biological factors are associated with the course of HRQOL from baseline to 24 months after treatment. Post-treatment social, lifestyle, and HNC-related factors are associated with the course of HRQOL from 6 to 24 months after treatment.
本前瞻性队列研究旨在评估头颈部癌症(HNC)诊断和治疗后前 2 年生活质量(HRQOL)的变化与个人、临床、心理、身体、社会、生活方式、HNC 相关和生物学因素之间的关系。
本研究使用了来自荷兰生活质量和生物医学队列研究(NET-QUBIC)的 638 名 HNC 患者的数据。采用线性混合模型来调查与 HRQOL 变化相关的因素(EORTC QLQ-C30 全球健康状况(QL)和总分(SumSc)),从治疗开始后 3、6、12 和 24 个月进行评估。
基线时的抑郁症状、社会接触和口腔疼痛与治疗后 24 个月内的 QL 变化显著相关。肿瘤部位和基线时的社交进食、压力(高唤醒)、咳嗽、不适和 IL-10 与 SumSc 的变化相关。治疗后社会接触和压力(回避)与治疗后 6 至 24 个月内的 QL 变化显著相关,社会接触和体重减轻与 SumSc 的变化相关。治疗后 6 至 24 个月内的 SumSc 变化还与基线至 6 个月期间财务问题、言语问题、体重减轻和肩部问题的变化显著相关。
基线时的临床、心理、社会、生活方式、HNC 相关和生物学因素与治疗后 24 个月内的 HRQOL 变化相关。治疗后 6 至 24 个月内的社会、生活方式和 HNC 相关因素与 HRQOL 的变化相关。